Article Details
Retrieved on: 2021-04-05 21:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vir Biotechnology Inc., of San Francisco, said preclinical data showed the ability of VIR-7831, its SARS-CoV-2 monoclonal antibody (MAb), to maintain ...
Article found on: www.bioworld.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here